New treatment strategies for human epidermal growth factor receptor 2-positive breast cancer in 2023 : Current Opinion in Obstetrics and Gynecology

Secondary Logo

Journal Logo

You can read the full text of this article if you:

Access through Ovid
REVIEW

New treatment strategies for human epidermal growth factor receptor 2-positive breast cancer in 2023

Banys-Paluchowski, Maggiea; Krawczyk, Nataliab; Stickeler, Elmarc; Müller, Volkmard; Fehm, Tanjab

Author Information
Current Opinion in Obstetrics and Gynecology: October 10, 2022 - Volume - Issue - 10.1097/GCO.0000000000000830
doi: 10.1097/GCO.0000000000000830
  • Buy
  • PAP

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.